IT & Data Management
CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review
CluePoints continues to transform clinical trial review and leverage its industry-leading software to enhance the interrogation, analysis and presentation of data with the launch of...
News
Phastar Announced as 2024 Scrip Award Finalist for Best Contract Research Organization – Specialist Provider
Phastar, global specialist biometrics contract research organization (CRO), has been named as a finalist for the Best Contract Research Organization - Specialist Providers category...
News
iNova Pharmaceuticals launches iPITCH 2024 – a global crowdsourcing initiative
iNova Pharmaceuticals, in partnership with CoVentured, is thrilled to launch ‘iPitch 2024’, a global crowdsourcing initiative which aims to discover the latest, science-backed innovations...
Clinical Trials
VerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the EFS with unprecedented yields
EVerZom, a biopharmaceutical company developing  exosome based biodrugs, announces that it has reached a key milestone in its development with the production of a first exosome GMP batch in a 10L...
News
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network
Emmes, part of Emmes Group, a leading specialty tech-enabled global contract research organization (CRO), has been selected by the National Institutes of Health’s (NIH) NIDA to support their Clinical Trials Network (CTN) for...
Drug Research
Revolutionizing Drug Valuation With Real-World Evidence
Determining the value of a medicine may be a challenging task. To put it another way, how much is the value of a patient's...
Drug Research
Role of AI In Transforming Drug Discovery And Development
Artificial Intelligence (AI) is transforming the pharmaceutical industry, driving significant advancements across various stages of drug discovery, development, and production. By leveraging AI technologies,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read